Elbasvir / Grazoprevir Oral Tablet

DRUG3 trials

Sponsors

National Taiwan University Hospital, University Hospital, Akershus, Bayside Health

Conditions

Hepatitis CHepatocellular CarcinomaHepatomaLiver Cell CarcinomaRenal DiseaseSubstance Use DisordersViral Hepatitis C

Phase 3

HepATocellular Cancer Hcv Therapy Study

WithdrawnNCT04546802

Bayside HealthHepatitis C, Hepatocellular Carcinoma, Hepatoma +1

Start: 2019-09-30End: 2023-06-30Updated: 2020-09-14

Unknown Phase

eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs

CompletedNCT04047680

National Taiwan University HospitalHepatitis C, Renal Disease, Viral Hepatitis C

Start: 2015-02-28End: 2019-06-30Updated: 2019-08-08

HCV Treatment in a Low-threshold Clinic

University Hospital, AkershusHepatitis C, Substance Use Disorders

Start: 2015-01-31End: 2022-12-31Target: 300Updated: 2019-08-21

Related Papers

Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals.

2019-11-2933 citations